Join us at the 10
th
Annual FDA/CMS Summit for Biopharma Executives.
Our keynote speakers and panels will take a deep dive into
each of these topics, and more.
Hear frst-hand from government and
industry experts on these important
issues:
• The commercial outlook for biopharma
under the new health care exchanges.
• Updates on the latest drug review statistics
from the Offce of New Drugs and industry's
experience under the new review "Program".
• The future of drug safety at FDA - both for
the increasingly popular rare disease drugs
as well as new treatments for large primary
care markets like obesity and diabetes.
• What's in store for the reauthorization of
PDUVA VI, and a preview of what's to come
as industry and FDA take a second look at
BsUFA and GDUFA.
• Coming changes to Medicare Part D and
what CMS has in store for the prescription
drug beneft.
• What the mid-term Congressional elections
will mean for the biopharma industry.
GOLD SPONSORS
2014 KEYNOTE SPEAKERS
SILVER SPONSOR
MEDIA PARTNERS
ASSOCIATION
Janet Woodcock, MD
Director - Center for
Drug Evaluation and
Research
FDA
John Jenkins, MD
Director - Offce of
New Drugs, Center
for Drug Evaluation
and Research
FDA
Trent T. Haywood,
MD, JD, SVP
Chief Medical Offcer
BlueCross
BlueShield
Association
BIO
For more information:
Email: register@iirusa.com
Call: 888-670-8200
For groups, contact Mills Thenor
at 646-895-7423 to customize your
team registration package.